Aveo says partner Astellas will not seek EU nod for kidney cancer drug

(Reuters) - Aveo Pharmaceuticals Inc said it was informed by its partner Astellas Pharma Inc that the Japanese company would not be seeking marketing approval for their experimental kidney cancer drug in Europe. Aveo shares fell about 13 percent i...

Source: http://health.yahoo.net/news/s/nm/aveo-says-partner-astellas-will-not-seek-eu-nod-for-kidney-cancer-drug

website view view site view website